SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-012773
Filing Date
2019-08-15
Accepted
2019-08-15 14:22:19
Documents
60
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 ex31-1.htm 10-Q 17070
2 form10-q.htm EX-32.1 1188324
3 ex31-2.htm EX-31.2 17103
4 ex32-1.htm EX-32.1 9728
  Complete submission text file 0001493152-19-012773.txt   6817017

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE obmp-20190630.xml EX-101.INS 1235482
6 XBRL SCHEMA FILE obmp-20190630.xsd EX-101.SCH 67199
7 XBRL CALCULATION FILE obmp-20190630_cal.xml EX-101.CAL 55916
8 XBRL DEFINITION FILE obmp-20190630_def.xml EX-101.DEF 270819
9 XBRL LABEL FILE obmp-20190630_lab.xml EX-101.LAB 461260
10 XBRL PRESENTATION FILE obmp-20190630_pre.xml EX-101.PRE 346754
Mailing Address 11441 INDUSTRIPLEX BLVD SUITE 190 BATON ROUGE LA 70809
Business Address 11441 INDUSTRIPLEX BLVD SUITE 190 BATON ROUGE LA 70809 225-227-2384
OncBioMune Pharmaceuticals, Inc (Filer) CIK: 0001362703 (see all company filings)

IRS No.: 202590810 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52218 | Film No.: 191029717
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences